Navigation Links
KaloBios Announces Fiscal Year 2012 Financial Results
Date:3/27/2013

ding at December 31, 2012, and 2011, respectively; aggregate liquidation preference of $105,512 at December 31, 2012

102,02383,178Stockholders' deficit: Common stock, $0.001 par value: 80,000,000 shares  60,000,000 shares authorized at December 31, 2012, and 2011, respectively; 2,186,695 and 1,986,431 shares issued and outstanding at December 31, 2012, and 2011, respectively

22Additional paid-in capital 

3,3172,412Accumulated other comprehensive income (loss) 

4(1)Accumulated deficit 

(98,267)(74,758)Total stockholders' deficit 

(94,944)(72,345)Total liabilities, convertible preferred stock and stockholders' deficit 

$
24,539$
9,347Consolidated Statements of OperationsYear Ended December 31, 2012 and 2011(in thousands, except share and per share information)(Unaudited)Year Ended December 31,20122011Contract revenue$
,098$   20,255Operating expenses:Research and development24,51918,512General and administrative5,0614,010Total operating expenses29,58022,522Loss from operations(23,482)(2,267)Other income (expense):Interest income (expense), net(140)43Other income (expense), net113(8)Net loss$ (23,509)$   (2,232)Basic and diluted net loss per common share$   (11.22)$
(1.15)Weighted average common shares outstanding used to calculate basic and diluted net loss per common share2,095,9501,933,672Stock based Compensation ExpenseYear Ended December 31, 2012 and 2011(in thousands)(Unaudited)Total stock-based compensation expense included in the consolidated statements of operations is as follows:Year Ended December 31,20122011Research and development$
398$
28General and administrative42393Total stock-based compensation expense$
821$
221 


'/>"/>
SOURCE KaloBios Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. CfPIE Announces Advisory Board to Support Continued Life Sciences Training Alignment with Industry Regulations
2. SoundConnect Announces Audio Conferencing Capacity Upgrades
3. BMI Surplus Announces Sale of Thermal Vacuum Space Simulation Chamber
4. XBiotech Announces Incorporation Of Its Wholly Owned Subsidiary XBiotech Japan KK
5. National Brain Tumor Society Announces Launch of Defeat GBM Research Collaborative
6. Regenerative Medicine Company, Eqalix, Announces Grant from Nanotechnology Institute in Philadelphia, Pennsylvania
7. Probiotics Are in More Than Just Yogurt: Probiotic Action Announces 5 New Items Containing the Healthy Bacteria
8. Synedgen Announces Issuance of Patent to Optimize Animal Health
9. Piramal Imaging Announces the Acceptance for Review of [18F] florbetaben by the FDA and EMA for the Visual Detection of beta-amyloid in Alzheimers Disease
10. Probiotic Action Announces Probiotics Pending Listing on EU Foods
11. Butamax Announces Immediate Appeal of Court Decisions on Claim Construction and Summary Judgment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... , April 30, 2015 Oxford Finance LLC ... to life sciences and healthcare services companies, today announced ... loan agreement with Celula, Inc., a diagnostic testing company ... enabling better patient care and improved outcomes.  Proceeds of ... and expand the commercialization of its products in the ...
(Date:4/30/2015)... 30, 2015  Pfenex Inc. (NYSE MKT: PFNX) ... of biosimilar therapeutics including high value and difficult ... its previously announced underwritten public offering of 6,750,000 ... offering price of $15.50 per share. This includes ... their option to purchase up to 750,000 additional ...
(Date:4/30/2015)... April 30, 2015 Available in ... http://www.lespausa.com , Fleur’s introduces ... combining the benefits of makeup, skin care and ... tinted cream is designed with specific complexion-correcting pigments ... even complexion and a healthy glow. Far more ...
(Date:4/30/2015)... (PRWEB) April 30, 2015 Sterlitech ... ultrafiltration membranes, the PX, PY, and PZ ... sheets, and disks. Designed to be ideal ... new membranes can fill critical process requirements where ... downstream processes. , “New regulations on industrial wastewater ...
Breaking Biology Technology:Oxford Finance Provides $10 Million Debt Financing to Celula 2Pfenex Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 2Fleur’s Introduces CC CRÈME Perfect Skin Solution 2Fleur’s Introduces CC CRÈME Perfect Skin Solution 3Sterlitech Offers New Ultrafiltration Membranes 2
... to $33.2 Million, ... $12.8 Million, -- The Company Provides ... NEW YORK and HAIKOU, Hainan, China, March 31,/Xinhua-PRNewswire-FirstCall/ -- ... which develops, manufactures, and,markets generic and branded bio-pharmaceutical products ...
... on Lead Compounds That Directly and Specifically Activate ... ... Massachusetts, March 31 Mercury Therapeutics,Inc. (MTI), a company that discovers ... filed for patent protection on,three lead compounds that directly and specifically ...
... Vaccine Technology and ... Bird Flu Clinical Program, Webcast/teleconference Call Set ... March 31 Carrington,Laboratories, Inc. (OTC Bulletin Board: CARN) today reported ... ($0.90) per basic and,diluted share, for the year ended December 31, ...
Cached Biology Technology:China Pharma Holdings, Inc. Announces Record 2007 Year End Results 2China Pharma Holdings, Inc. Announces Record 2007 Year End Results 3China Pharma Holdings, Inc. Announces Record 2007 Year End Results 4China Pharma Holdings, Inc. Announces Record 2007 Year End Results 5China Pharma Holdings, Inc. Announces Record 2007 Year End Results 6China Pharma Holdings, Inc. Announces Record 2007 Year End Results 7China Pharma Holdings, Inc. Announces Record 2007 Year End Results 8China Pharma Holdings, Inc. Announces Record 2007 Year End Results 9China Pharma Holdings, Inc. Announces Record 2007 Year End Results 10China Pharma Holdings, Inc. Announces Record 2007 Year End Results 11Mercury Therapeutics Patents Filed 2Mercury Therapeutics Patents Filed 3Carrington Reports 2007 Financial Results 2Carrington Reports 2007 Financial Results 3Carrington Reports 2007 Financial Results 4Carrington Reports 2007 Financial Results 5Carrington Reports 2007 Financial Results 6Carrington Reports 2007 Financial Results 7
(Date:3/24/2015)... March 24, 2015   NexID Biometrics LLC, ... security-authentication needs, today announced the beginning of shipments of ... The company, based in Potsdam, ... three-day Connect:ID Expo, which began here today at the ... version 2.0 of its SDK boosts the accuracy rate ...
(Date:3/23/2015)... --  HOYOS Labs , a leading global authentication infrastructure ... Company will demonstrate multiple biometrics-based technologies under its identity ... on March 23 through 25, 2015, in ... IEEE Biometric Open Protocol Standard; free biometrics-based consumer app, ... system. BOPS was invented by HOYOS Labs and contributed ...
(Date:3/20/2015)... Research and Markets ( http://www.researchandmarkets.com/research/4stcg3/india_sensors ... "India Sensors Market Forecast and Opportunities 2020" ... market is projected to grow at a CAGR ... automotive, industrial and healthcare sectors are the key ... addition, adoption of MEMS technology in sensors is ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3
... . . . ,Researchers at the Bio-SANS instrument ... and small-angle neutron scattering to get a first insight ... complexes. The unique properties of polyelectrolyte materials are of ... membrane -- three-dimensional bio-scaffolds to grow cells for regenerating ...
... of Medicine, Hershey, Pennsylvania have discovered that the presence ... which mediates the inhibitory action of opioid growth factor ... the progression and treatment of human ovarian cancer. ... engineered to have a reduced expression of OGFr, into ...
... threats to tropical coral reefs can be a population outbreak ... can consume live corals over large areas, a change that ... the aesthetic value of coral reefs, which in turn negatively ... triggers and spread of COT outbreaks are not fully understood. ...
Cached Biology News:Feb. 21, 2012, story tips 2Feb. 21, 2012, story tips 3A breakthrough in understanding the biology and treatment of ovarian cancer 2A breakthrough in understanding the biology and treatment of ovarian cancer 3Coral-eating sea star invaders turn out to be locals 2
... making flow cytometry accessible to anyone in the ... latest addition to Guavas on-demand microcapillary flow cytometry ... to use, surprisingly affordable, very compact, and nicely ... The Guava EasyCyte Mini has all of the ...
... unique combination of Coulter volume and ... and accurate cell counting. This flow ... UV, allowing flexible fluorochrome selection for ... only achievable with larger, more expensive ...
... crosslinked to protein G-agarose beads which can ... heart mitochondria. Also included are 2 mg ... ,The pyruvate dehydrogenase complex (PDH) immunocapture kit ... of tissue. This facilitates the subsequent analysis ...
... Protein/antibody delivery using PULSin may be superior ... example, unlike traditional transfection, with PULSin you ... level and time course of proteins in ... provide more information than traditional RNA interference ...
Biology Products: